Confirmation of higher costs of care associated with lower health literacy suggests that interventions might be designed to remediate health literacy needs and reduce expenditures.
NL was responsible for providing data, reviewing the manuscript and providing independent confirmation of the cost-effectiveness results.
Feasibility data outcomes included the success of screening and recruitment strategies; data collection and entry processes; confirmation of Research Nurse time and cost, and produced further estimates of ventilation times and medication dosing, which can be used to finalise sample size requirements for the larger trial, and inform funding applications for same.
It may be useful to incorporate the routine use of molecular protocols such as 16S rRNA PCR and sequencing as an initial screen for microbial pathogens in clinical samples, this would allow more selective and efficient use of traditional culturing for confirmation, the cost of the molecular methods being offset by using less traditional culture associated consumables.
We have partitioned the estimation of costs into four parts: screening and diagnosis confirmation, initial treatment, follow-up and advanced care costs.
The critically ill, despite significant advances in their supportive care, remain at high risk of developing severe infections and organ failure, which carry a high mortality and healthcare costs. 2 3 Confirmation of infection in this setting depends on identification of live micro-organisms (pathogens) by microbiological culture of samples such as blood.
We used formal decision analysis to assess the cost-effectiveness of alternative HAT confirmation algorithms in terms of cost per life saved.
Compared with surgery performed on the basis of clinical findings alone, FNB reduces the number of thyroidectomies by approximately 50%, roughly doubles the surgical confirmation of carcinoma, and reduces the overall cost of medical care by 25%.
Assuming that a time cost for laboratory confirmation of diagnosis is sometimes inevitable, daily numbers of infected cases and daily-cumulative number of infected cases may be underestimated during an epidemic.
However, the application of molecular tests to known grade 1 and grade 3 breast cancers in the treatment decision-making process may need further validation and confirmation of any additional prognostic value and cost benefit.
Among the broad strategies, culture confirmation of rifampin-resistant tests on Xpert saved costs with little reduction in effectiveness.
